Literature DB >> 14688106

Immunogenicity of gonococcal transferrin binding proteins during natural infections.

Gregory A Price1, Marcia M Hobbs, Cynthia Nau Cornelissen.   

Abstract

In this study, we examined the immune response during gonococcal infection to the individual transferrin binding proteins by using a quantitative enzyme-linked immunosorbent assay (ELISA). Recombinant transferrin binding protein A (rTbpA) and rTbpB were purified under nondenaturing conditions for use as ELISA antigens. Sera and secretions from culture-positive individuals were analyzed for antibodies to rTbpA and rTbpB and compared to samples from individuals with no history of gonococcal infection. Although antibodies to both rTbpA and rTbpB were detected in serum, in most cases the antibody levels were not significantly different from those measured in the control population. Also, previous history of gonococcal infection did not increase antibody levels in serum, suggesting the lack of an anamnestic response. Analysis of secretion samples revealed antibody levels that were generally below the limits of detection in our assay. Overall, this study demonstrated a paucity of systemic and local antibody responses to rTbps as a result of natural infection and represents a baseline over which a protective antibody response will have to be generated in order to develop an efficacious gonococcal vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688106      PMCID: PMC343986          DOI: 10.1128/IAI.72.1.277-283.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Serum antibody response in experimental human gonorrhoea. Immunoglobulins G, A, and M.

Authors:  I R Cohen; D S Kellogg; L C Norins
Journal:  Br J Vener Dis       Date:  1969-12

2.  Gonococcal vaccine studies in Inuvik.

Authors:  L Greenberg; B B Diena; F A Ashton; R Wallace; C P Kenny; R Znamirowski; H Ferrari; J Atkinson
Journal:  Can J Public Health       Date:  1974 Jan-Feb

3.  Recidivism among patients with gonococcal infection presenting to a venereal disease clinic.

Authors:  R C Noble; N M Kirk; W A Slagel; B J Vance; G W Somes
Journal:  Sex Transm Dis       Date:  1977 Apr-Jun       Impact factor: 2.830

4.  Antibodies to Neisseria gonorrhoeae: a study of the urethral exudates of 232 men.

Authors:  A McMillan; G McNeillage; H Young
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

5.  Secretory antibody response of the cervix to infection with Neisseria gonorrhoeae.

Authors:  A McMillan; G McNeillage; H Young; S S Bain
Journal:  Br J Vener Dis       Date:  1979-08

6.  Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes.

Authors:  Ian C Boulton; Scott D Gray-Owen
Journal:  Nat Immunol       Date:  2002-02-19       Impact factor: 25.606

7.  Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection.

Authors:  D West; K Reddin; M Matheson; R Heath; S Funnell; M Hudson; A Robinson; A Gorringe
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  Serum and secretory antibody responses to Neisseria gonorrhoeae in patients with gonococcal infections.

Authors:  P Tapchaisri; S Sirisinha
Journal:  Br J Vener Dis       Date:  1976-12

9.  Serum immunoglobulin response in uncomplicated gonorrhoea.

Authors:  A McMillan; G McNeillage; H Young; S R Bain
Journal:  Br J Vener Dis       Date:  1979-02

10.  Immunity to tetanus in Finland.

Authors:  M K Viljanen; S Nieminen
Journal:  Scand J Infect Dis       Date:  1980
View more
  16 in total

1.  Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae.

Authors:  Devin R Cash; Nicholas Noinaj; Susan K Buchanan; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

2.  Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice.

Authors:  Gregory A Price; Heather P Masri; Aimee M Hollander; Michael W Russell; Cynthia Nau Cornelissen
Journal:  Vaccine       Date:  2007-08-06       Impact factor: 3.641

Review 3.  Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.

Authors:  C N Cornelissen
Journal:  Future Microbiol       Date:  2008-06       Impact factor: 3.165

4.  Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice.

Authors:  Guocai Li; Hongmei Jiao; Guihua Jiang; Jing Wang; Litian Zhu; Rushan Xie; Hua Yan; Hongju Chen; Mingchun Ji
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

5.  Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.

Authors:  Gregory A Price; Michael W Russell; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  The gonococcal Fur-regulated tbpA and tbpB genes are expressed during natural mucosal gonococcal infection.

Authors:  Sarika Agarwal; Carol A King; Ellen K Klein; David E Soper; Peter A Rice; Lee M Wetzler; Caroline A Genco
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

7.  Identification of transferrin-binding domains in TbpB expressed by Neisseria gonorrhoeae.

Authors:  Amanda J DeRocco; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

8.  Extragenital manifestations of Neisseria gonorrhoeae.

Authors:  Steven E Spencer; Margaret C Bash
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

Review 9.  The transferrin-iron import system from pathogenic Neisseria species.

Authors:  Nicholas Noinaj; Susan K Buchanan; Cynthia Nau Cornelissen
Journal:  Mol Microbiol       Date:  2012-09-07       Impact factor: 3.501

10.  Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection.

Authors:  B Feinen; A E Jerse; S L Gaffen; M W Russell
Journal:  Mucosal Immunol       Date:  2010-01-27       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.